The dual GIP & GLP-1 receptor co-agonist is an advanced research molecule engineered to activate both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, offering a unique dual mechanism of action.
To order please email info@biotekpeptides.com
The dual GIP & GLP-1 receptor co-agonist is an advanced research molecule engineered to activate both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, offering a unique dual mechanism of action.
To order please email info@biotekpeptides.com
The dual GIP/GLP-1 receptor co-agonist is a next-generation research molecule engineered to simultaneously activate both GIP and GLP-1 receptors in non-human test subjects. This dual action allows researchers to study complex metabolic pathways, energy balance, and receptor interactions, offering a powerful tool for exploring innovative therapeutic strategies.
